tirzepatide surpass cvot In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx Diabetes Distilled: SURPASS-CVOT – Tirzepatide

The majority of the subjects (84% of those prescribed semaglutide and 100% of those prescribed tirzepatide) were also overweight or obese

There is no MHRA-approved or manufacturer-validated answer to this question, as retatrutide holds no UK marketing authorisation

Is it safe, and what are the side effects

Vary your food choices: A balanced diet includes a wide variety of foods to ensure an adequate intake of vitamins, minerals, and other nutrients

Bai Y, Ma K, Li J, Li J, Bi C, Shan A (2021) Deoxynivalenol exposure induces liver damage in mice: inflammation and immune responses, oxidative stress, and protective effects of Lactobacillus rhamnosus GG

Setria Glutathione - the most bioavailable form of glutathione